GlassScriptPhysician profile
David H Daniels
NPI 1538394952
$3,215.26
in general payments reported to CMS, 2019-2025
41 companies · $648 in 2025
The $648 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $205 · 2021: $208 · 2022: $530 · 2023: $660 · 2024: $531 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $381.88 | 2019-2023 | Xtandi, Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $324.95 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $225.43 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Myriad Genetic Laboratories, INC. | $208.30 | 2023 | Prolaris |
| Abbvie INC. | $204.06 | 2019-2025 | Botox |
| Histosonics, INC. | $170.62 | 2025 | |
| Boston Scientific Corporation | $152.48 | 2020-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| 180 Medical, INC. | $123.89 | 2019-2025 | Gentlecath Glide, Cure Catheter, Gentlecath |
| Pfizer INC. | $122.54 | 2023-2025 | |
| Axonics, INC. | $112.55 | 2021-2024 | Axonics |
| Medtronic, INC. | $105.90 | 2021-2023 | Interstim |
| Tolmar Pharmaceuticals, INC. | $98.72 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $82.80 | 2023-2024 | |
| Amgen INC. | $76.24 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $70.80 | 2021-2024 | Keytruda, Lynparza |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.